A microarray analysis assessed the levels of FOXD1 mRNA in non-small cell lung cancer (NSCLC) and found that the levels were significantly associated with patient survival by disturbing cell proliferation [17]. The gene discussed is FOXD1; the disease is non-small cell lung carcinoma.